24 May 2013
Keywords: UCB, Oxford University, Research projects, Academia, Funding
Article | 19 March 2012
The UK subsidiary of Belgian drugmaker UCB (Euronext Brussels: UCB) said yesterday that it has agreed to collaborate on cutting-edge ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 March 2012
20 March 2012
23 May 2013
© 2013 thepharmaletter.com